INSPIRE Turkey :A Research Study Looking at the Clinical Parameters Associated With Use and Discontinuation of Saxenda ® in Local Clinical Practice in Turkey by Analysing Past Patient Medical Records
Condition: Obesity Intervention: Drug: Liraglutide Sponsor: Novo Nordisk A/S Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - June 29, 2022 Category: Research Source Type: clinical trials
